Efficacy and Safety of Asfotase Alfa in Infants and Young Children With Hypophosphatasia: A Phase 2 Open-Label Study

CONTEXT: Long-term data on enzyme replacement treatment of hypophosphatasia (HPP) are limited. OBJECTIVE: To evaluate efficacy and safety of asfotase alfa in patients aged ≤5 years with HPP followed for up to 6 years. DESIGN: Phase 2 open-label study (July 2010 to September 2016). SETTING: Twenty-tw...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Clin Endocrinol Metab
Main Authors: Hofmann, Christine E, Harmatz, Paul, Vockley, Jerry, Högler, Wolfgang, Nakayama, Hideki, Bishop, Nick, Martos-Moreno, Gabriel Á, Moseley, Scott, Fujita, Kenji P, Liese, Johannes, Rockman-Greenberg, Cheryl
Format: Artigo
Sprog:Inglês
Udgivet: Endocrine Society 2019
Fag:
Clinical Research Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6530655/
https://ncbi.nlm.nih.gov/pubmed/30811537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2018-02335
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker